Alexander Horswill
Concepts (642)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 114 | 2025 | 452 | 25.630 |
Why?
| | Staphylococcal Infections | 95 | 2025 | 401 | 22.810 |
Why?
| | Bacterial Proteins | 86 | 2025 | 895 | 11.850 |
Why?
| | Biofilms | 56 | 2025 | 259 | 11.450 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 42 | 2025 | 234 | 11.220 |
Why?
| | Quorum Sensing | 35 | 2024 | 77 | 8.570 |
Why?
| | Gene Expression Regulation, Bacterial | 39 | 2025 | 325 | 5.650 |
Why?
| | Staphylococcus epidermidis | 24 | 2024 | 77 | 5.550 |
Why?
| | Skin | 20 | 2025 | 745 | 4.700 |
Why?
| | Virulence Factors | 26 | 2025 | 166 | 4.570 |
Why?
| | Staphylococcus | 11 | 2022 | 76 | 3.520 |
Why?
| | Virulence | 28 | 2025 | 265 | 3.370 |
Why?
| | Staphylococcal Skin Infections | 9 | 2025 | 35 | 3.140 |
Why?
| | Trans-Activators | 18 | 2023 | 397 | 3.130 |
Why?
| | Peptides, Cyclic | 19 | 2019 | 259 | 3.050 |
Why?
| | Bacterial Adhesion | 14 | 2025 | 98 | 3.020 |
Why?
| | Anti-Bacterial Agents | 34 | 2024 | 1799 | 2.820 |
Why?
| | Peptides | 17 | 2024 | 980 | 2.190 |
Why?
| | Neutrophils | 21 | 2025 | 1234 | 1.890 |
Why?
| | Host-Pathogen Interactions | 14 | 2024 | 364 | 1.820 |
Why?
| | Protein Kinases | 8 | 2022 | 319 | 1.720 |
Why?
| | Adhesins, Bacterial | 9 | 2025 | 39 | 1.680 |
Why?
| | Micrococcal Nuclease | 7 | 2024 | 25 | 1.590 |
Why?
| | Hemolysin Proteins | 9 | 2018 | 34 | 1.540 |
Why?
| | Dermatitis, Atopic | 4 | 2024 | 328 | 1.530 |
Why?
| | Mice | 58 | 2025 | 17731 | 1.490 |
Why?
| | Animals | 85 | 2025 | 36768 | 1.480 |
Why?
| | Phagocytosis | 11 | 2025 | 379 | 1.430 |
Why?
| | Lipoproteins | 5 | 2024 | 167 | 1.430 |
Why?
| | Membrane Proteins | 8 | 2024 | 1162 | 1.370 |
Why?
| | Peptide Hydrolases | 11 | 2024 | 111 | 1.300 |
Why?
| | Mutagenesis | 3 | 2025 | 182 | 1.260 |
Why?
| | Bacterial Toxins | 12 | 2020 | 105 | 1.250 |
Why?
| | Coinfection | 4 | 2023 | 136 | 1.210 |
Why?
| | Keratinocytes | 6 | 2024 | 248 | 1.160 |
Why?
| | Immune Evasion | 7 | 2021 | 58 | 1.150 |
Why?
| | Pruritus | 2 | 2024 | 63 | 1.060 |
Why?
| | Prosthesis-Related Infections | 3 | 2025 | 80 | 1.040 |
Why?
| | Vagina | 3 | 2025 | 186 | 1.020 |
Why?
| | Fibrinogen | 6 | 2023 | 168 | 1.020 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 95 | 1.010 |
Why?
| | Microbial Interactions | 2 | 2019 | 18 | 1.000 |
Why?
| | Humans | 105 | 2025 | 136783 | 0.980 |
Why?
| | DNA, Bacterial | 7 | 2024 | 336 | 0.980 |
Why?
| | Culture Media | 4 | 2024 | 167 | 0.970 |
Why?
| | Polysaccharide-Lyases | 2 | 2016 | 11 | 0.970 |
Why?
| | Propionates | 8 | 2020 | 39 | 0.950 |
Why?
| | Microbial Sensitivity Tests | 14 | 2024 | 356 | 0.940 |
Why?
| | Streptococcus pyogenes | 2 | 2023 | 45 | 0.930 |
Why?
| | Repressor Proteins | 4 | 2015 | 424 | 0.900 |
Why?
| | Genome, Bacterial | 1 | 2025 | 142 | 0.860 |
Why?
| | Extracellular Space | 4 | 2014 | 119 | 0.840 |
Why?
| | Endodeoxyribonucleases | 1 | 2023 | 71 | 0.790 |
Why?
| | Mutation | 26 | 2025 | 3953 | 0.740 |
Why?
| | Bacteremia | 4 | 2020 | 209 | 0.730 |
Why?
| | Cathepsin G | 1 | 2021 | 6 | 0.730 |
Why?
| | Metalloproteases | 2 | 2020 | 43 | 0.730 |
Why?
| | Microbiota | 7 | 2025 | 761 | 0.720 |
Why?
| | Agglutination Tests | 1 | 2021 | 4 | 0.710 |
Why?
| | Cell Membrane | 7 | 2021 | 736 | 0.710 |
Why?
| | Symbiosis | 2 | 2020 | 79 | 0.690 |
Why?
| | Microbial Viability | 3 | 2018 | 91 | 0.680 |
Why?
| | Metalloendopeptidases | 5 | 2017 | 62 | 0.680 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2020 | 591 | 0.660 |
Why?
| | Mass Spectrometry | 8 | 2019 | 739 | 0.640 |
Why?
| | Disease Models, Animal | 20 | 2025 | 4279 | 0.620 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 78 | 0.620 |
Why?
| | Plant Extracts | 4 | 2020 | 200 | 0.620 |
Why?
| | Rabbits | 10 | 2019 | 789 | 0.610 |
Why?
| | Membrane Transport Proteins | 1 | 2020 | 162 | 0.610 |
Why?
| | Immunity, Innate | 8 | 2021 | 826 | 0.600 |
Why?
| | Salmonella enterica | 6 | 2003 | 57 | 0.590 |
Why?
| | Dehydration | 1 | 2018 | 52 | 0.580 |
Why?
| | Antibiosis | 1 | 2017 | 10 | 0.570 |
Why?
| | Disease Transmission, Infectious | 1 | 2018 | 61 | 0.570 |
Why?
| | Yersinia pestis | 3 | 2013 | 45 | 0.560 |
Why?
| | Mice, Inbred C57BL | 18 | 2021 | 5744 | 0.540 |
Why?
| | Salmonella typhimurium | 7 | 2004 | 182 | 0.540 |
Why?
| | Coenzyme A Ligases | 4 | 2003 | 13 | 0.540 |
Why?
| | Carrier Proteins | 4 | 2022 | 768 | 0.540 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.530 |
Why?
| | Catheter-Related Infections | 8 | 2022 | 80 | 0.520 |
Why?
| | Operating Rooms | 1 | 2018 | 122 | 0.520 |
Why?
| | Pseudomonas aeruginosa | 7 | 2023 | 351 | 0.520 |
Why?
| | Cysteine Endopeptidases | 2 | 2013 | 72 | 0.510 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.490 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.490 |
Why?
| | Genes, Bacterial | 8 | 2014 | 165 | 0.490 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.480 |
Why?
| | Bacteriological Techniques | 2 | 2014 | 71 | 0.480 |
Why?
| | Mice, Inbred BALB C | 7 | 2022 | 1267 | 0.460 |
Why?
| | Lactones | 2 | 2013 | 56 | 0.460 |
Why?
| | Gram-Positive Bacteria | 2 | 2017 | 49 | 0.460 |
Why?
| | Models, Molecular | 11 | 2021 | 1591 | 0.460 |
Why?
| | Transduction, Genetic | 2 | 2014 | 126 | 0.460 |
Why?
| | Endonucleases | 1 | 2014 | 32 | 0.440 |
Why?
| | Hyaluronic Acid | 1 | 2016 | 221 | 0.430 |
Why?
| | Extracellular Matrix | 3 | 2020 | 527 | 0.430 |
Why?
| | Environment | 1 | 2016 | 362 | 0.430 |
Why?
| | Peptide Library | 6 | 2007 | 88 | 0.430 |
Why?
| | beta-Lactams | 2 | 2016 | 33 | 0.410 |
Why?
| | Citrates | 4 | 2004 | 44 | 0.410 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 12 | 0.410 |
Why?
| | Bacteriophages | 2 | 2014 | 95 | 0.410 |
Why?
| | Plasmids | 7 | 2013 | 362 | 0.400 |
Why?
| | Protein Binding | 9 | 2024 | 2223 | 0.400 |
Why?
| | Sigma Factor | 2 | 2011 | 40 | 0.400 |
Why?
| | Bone Remodeling | 1 | 2013 | 75 | 0.400 |
Why?
| | Bacillus thuringiensis | 1 | 2012 | 5 | 0.400 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.400 |
Why?
| | Lectins | 2 | 2024 | 49 | 0.400 |
Why?
| | Berberine | 1 | 2012 | 6 | 0.390 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 925 | 0.390 |
Why?
| | Superantigens | 4 | 2013 | 70 | 0.390 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1500 | 0.380 |
Why?
| | Epithelial Cells | 4 | 2024 | 1093 | 0.380 |
Why?
| | Synovial Fluid | 4 | 2022 | 69 | 0.380 |
Why?
| | Gene Library | 2 | 2010 | 117 | 0.380 |
Why?
| | Pneumonia, Bacterial | 2 | 2023 | 116 | 0.380 |
Why?
| | Fibronectins | 3 | 2022 | 133 | 0.380 |
Why?
| | Coagulase | 3 | 2021 | 6 | 0.370 |
Why?
| | Locomotion | 1 | 2012 | 104 | 0.360 |
Why?
| | Wound Infection | 2 | 2023 | 32 | 0.360 |
Why?
| | Cytotoxins | 3 | 2024 | 16 | 0.360 |
Why?
| | Osteomyelitis | 1 | 2013 | 132 | 0.360 |
Why?
| | Signal Transduction | 10 | 2024 | 5065 | 0.350 |
Why?
| | Genes, Reporter | 3 | 2019 | 268 | 0.350 |
Why?
| | Proteins | 3 | 2006 | 1009 | 0.350 |
Why?
| | Extracellular Traps | 2 | 2021 | 53 | 0.350 |
Why?
| | Community-Acquired Infections | 2 | 2010 | 171 | 0.350 |
Why?
| | Serine Endopeptidases | 3 | 2011 | 123 | 0.350 |
Why?
| | Amoxicillin | 2 | 2024 | 30 | 0.340 |
Why?
| | Plasma | 1 | 2012 | 213 | 0.330 |
Why?
| | Hydrogen-Ion Concentration | 4 | 2022 | 564 | 0.330 |
Why?
| | Luminescent Proteins | 3 | 2011 | 178 | 0.320 |
Why?
| | Internal Fixators | 1 | 2010 | 36 | 0.320 |
Why?
| | Peptide Biosynthesis | 1 | 2009 | 13 | 0.320 |
Why?
| | Amino Acid Sequence | 11 | 2016 | 2145 | 0.310 |
Why?
| | Models, Biological | 8 | 2021 | 1769 | 0.310 |
Why?
| | Anacardiaceae | 2 | 2020 | 4 | 0.310 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2903 | 0.300 |
Why?
| | Macrophages | 5 | 2025 | 1541 | 0.300 |
Why?
| | Operon | 6 | 2018 | 65 | 0.300 |
Why?
| | Polysaccharides | 3 | 2021 | 84 | 0.300 |
Why?
| | Anti-Infective Agents | 4 | 2023 | 254 | 0.300 |
Why?
| | Drug Discovery | 3 | 2019 | 141 | 0.290 |
Why?
| | Cells, Cultured | 9 | 2021 | 4194 | 0.290 |
Why?
| | Recombinant Proteins | 7 | 2015 | 1354 | 0.290 |
Why?
| | DnaB Helicases | 1 | 2007 | 2 | 0.280 |
Why?
| | Female | 27 | 2025 | 72840 | 0.280 |
Why?
| | Inteins | 1 | 2007 | 3 | 0.280 |
Why?
| | Synechocystis | 1 | 2007 | 3 | 0.280 |
Why?
| | Sepsis | 3 | 2023 | 611 | 0.280 |
Why?
| | Cysteine Proteases | 2 | 2020 | 7 | 0.280 |
Why?
| | Extracellular Matrix Proteins | 2 | 2024 | 152 | 0.270 |
Why?
| | Hypochlorous Acid | 2 | 2025 | 8 | 0.270 |
Why?
| | Cyclohexanones | 2 | 2017 | 9 | 0.270 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1250 | 0.270 |
Why?
| | Acyl Coenzyme A | 4 | 2003 | 31 | 0.260 |
Why?
| | Biological Assay | 3 | 2015 | 123 | 0.260 |
Why?
| | Protein Engineering | 2 | 2004 | 109 | 0.250 |
Why?
| | Base Sequence | 4 | 2023 | 2180 | 0.240 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2014 | 387 | 0.240 |
Why?
| | Malassezia | 1 | 2025 | 5 | 0.240 |
Why?
| | Gain of Function Mutation | 1 | 2025 | 36 | 0.240 |
Why?
| | Mycobiome | 1 | 2025 | 9 | 0.240 |
Why?
| | Adenosine Monophosphate | 2 | 2003 | 66 | 0.230 |
Why?
| | Antimicrobial Cationic Peptides | 4 | 2023 | 81 | 0.230 |
Why?
| | Porosity | 1 | 2025 | 99 | 0.230 |
Why?
| | Aconitate Hydratase | 2 | 2002 | 17 | 0.230 |
Why?
| | Molecular Biology | 1 | 2005 | 58 | 0.230 |
Why?
| | Inflammation | 8 | 2023 | 2834 | 0.230 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1089 | 0.230 |
Why?
| | Escherichia coli | 3 | 2009 | 812 | 0.230 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 30 | 0.220 |
Why?
| | Coculture Techniques | 2 | 2016 | 239 | 0.220 |
Why?
| | Endocarditis | 2 | 2016 | 38 | 0.220 |
Why?
| | Isocitrates | 2 | 2001 | 2 | 0.220 |
Why?
| | Oxo-Acid-Lyases | 2 | 2001 | 3 | 0.220 |
Why?
| | Structure-Activity Relationship | 3 | 2023 | 573 | 0.220 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2024 | 2 | 0.220 |
Why?
| | Corynebacterium | 1 | 2024 | 49 | 0.220 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 41 | 0.220 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1428 | 0.220 |
Why?
| | Biology | 1 | 2005 | 87 | 0.220 |
Why?
| | Trypsin | 1 | 2024 | 77 | 0.220 |
Why?
| | Receptor, PAR-1 | 1 | 2023 | 16 | 0.220 |
Why?
| | Succinates | 1 | 2023 | 23 | 0.210 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 183 | 0.210 |
Why?
| | Dermatitis | 1 | 2023 | 20 | 0.210 |
Why?
| | alpha-Defensins | 2 | 2021 | 10 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 115 | 0.210 |
Why?
| | Swine | 4 | 2017 | 773 | 0.210 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 282 | 0.210 |
Why?
| | Microscopy, Confocal | 3 | 2014 | 322 | 0.210 |
Why?
| | Enzymes | 1 | 2004 | 67 | 0.210 |
Why?
| | Fatty Acids | 2 | 2025 | 444 | 0.210 |
Why?
| | Microscopy, Fluorescence | 3 | 2016 | 397 | 0.200 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.200 |
Why?
| | RNA, Bacterial | 4 | 2013 | 190 | 0.200 |
Why?
| | Streptococcus pneumoniae | 1 | 2024 | 169 | 0.200 |
Why?
| | Enzyme Inhibitors | 5 | 2008 | 838 | 0.200 |
Why?
| | Respiratory System | 2 | 2016 | 157 | 0.200 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2023 | 55 | 0.200 |
Why?
| | Streptococcal Infections | 2 | 2023 | 151 | 0.200 |
Why?
| | Exotoxins | 2 | 2013 | 16 | 0.200 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 181 | 0.200 |
Why?
| | Lipase | 2 | 2021 | 68 | 0.200 |
Why?
| | Staphylococcus hominis | 1 | 2022 | 2 | 0.200 |
Why?
| | Cephalexin | 1 | 2022 | 12 | 0.190 |
Why?
| | Reactive Oxygen Species | 2 | 2024 | 618 | 0.190 |
Why?
| | DNA Transposable Elements | 4 | 2010 | 122 | 0.190 |
Why?
| | Polysaccharides, Bacterial | 3 | 2017 | 70 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2023 | 193 | 0.190 |
Why?
| | Bacterial Load | 4 | 2015 | 68 | 0.190 |
Why?
| | Genotype | 4 | 2019 | 1919 | 0.190 |
Why?
| | Epidermis | 2 | 2020 | 157 | 0.190 |
Why?
| | Cell Communication | 2 | 2018 | 314 | 0.180 |
Why?
| | Basophils | 1 | 2021 | 73 | 0.180 |
Why?
| | Cell Death | 2 | 2021 | 370 | 0.180 |
Why?
| | Male | 21 | 2022 | 67361 | 0.180 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 65 | 0.180 |
Why?
| | Propionibacteriaceae | 1 | 2020 | 2 | 0.180 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2001 | 67 | 0.180 |
Why?
| | Pyruvic Acid | 1 | 2001 | 54 | 0.180 |
Why?
| | Hair Follicle | 1 | 2021 | 46 | 0.180 |
Why?
| | Interleukin-17 | 2 | 2019 | 120 | 0.170 |
Why?
| | Orthopedic Equipment | 1 | 2020 | 5 | 0.170 |
Why?
| | Interleukin-4 | 1 | 2021 | 217 | 0.170 |
Why?
| | Chemotaxis | 1 | 2021 | 130 | 0.170 |
Why?
| | Molecular Structure | 4 | 2020 | 495 | 0.170 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 1059 | 0.170 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2018 | 23 | 0.170 |
Why?
| | Photosensitizing Agents | 1 | 2020 | 34 | 0.170 |
Why?
| | Phage Therapy | 1 | 2020 | 15 | 0.170 |
Why?
| | Photochemotherapy | 1 | 2020 | 37 | 0.170 |
Why?
| | Shear Strength | 1 | 2020 | 67 | 0.170 |
Why?
| | Dysbiosis | 1 | 2022 | 180 | 0.170 |
Why?
| | Fatty Acids, Volatile | 1 | 2020 | 58 | 0.170 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 71 | 0.170 |
Why?
| | Netherton Syndrome | 1 | 2020 | 3 | 0.170 |
Why?
| | Triterpenes | 1 | 2020 | 21 | 0.170 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 867 | 0.170 |
Why?
| | Phylogeny | 1 | 2024 | 896 | 0.160 |
Why?
| | Antigens, Bacterial | 1 | 2020 | 129 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 146 | 0.160 |
Why?
| | Blotting, Western | 4 | 2016 | 1225 | 0.160 |
Why?
| | Gene Deletion | 4 | 2014 | 392 | 0.160 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.160 |
Why?
| | Genomics | 1 | 2005 | 790 | 0.160 |
Why?
| | Lysine | 1 | 2002 | 293 | 0.160 |
Why?
| | Coleoptera | 1 | 2019 | 28 | 0.160 |
Why?
| | Streptococcus agalactiae | 2 | 2023 | 93 | 0.160 |
Why?
| | Luciferases | 1 | 2019 | 150 | 0.160 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 45 | 0.160 |
Why?
| | Bacteria | 3 | 2023 | 855 | 0.160 |
Why?
| | Pyrazines | 1 | 2020 | 91 | 0.160 |
Why?
| | Leishmania major | 1 | 2019 | 8 | 0.160 |
Why?
| | Fruit | 1 | 2020 | 138 | 0.160 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 14 | 0.160 |
Why?
| | Cathelicidins | 4 | 2023 | 41 | 0.150 |
Why?
| | Static Electricity | 1 | 2019 | 120 | 0.150 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1768 | 0.150 |
Why?
| | Skin Diseases | 2 | 2019 | 148 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 144 | 0.150 |
Why?
| | Models, Genetic | 2 | 2016 | 605 | 0.150 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 16 | 0.150 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 182 | 0.150 |
Why?
| | Pneumonia, Staphylococcal | 2 | 2018 | 23 | 0.140 |
Why?
| | Lung | 5 | 2022 | 4065 | 0.140 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 200 | 0.140 |
Why?
| | Environmental Microbiology | 1 | 2018 | 53 | 0.140 |
Why?
| | NADPH Oxidases | 2 | 2021 | 110 | 0.140 |
Why?
| | Bordetella bronchiseptica | 1 | 2017 | 2 | 0.140 |
Why?
| | Bordetella Infections | 1 | 2017 | 4 | 0.140 |
Why?
| | Teichoic Acids | 2 | 2022 | 14 | 0.140 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 224 | 0.140 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 152 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 576 | 0.140 |
Why?
| | Substrate Specificity | 4 | 2007 | 384 | 0.140 |
Why?
| | Transcription, Genetic | 3 | 2008 | 1453 | 0.140 |
Why?
| | Conserved Sequence | 2 | 2011 | 240 | 0.130 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 257 | 0.130 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2017 | 70 | 0.130 |
Why?
| | Cell Line | 4 | 2015 | 2836 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 467 | 0.130 |
Why?
| | Endocarditis, Bacterial | 2 | 2013 | 42 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 624 | 0.130 |
Why?
| | Ligases | 1 | 2016 | 32 | 0.130 |
Why?
| | Vascular Access Devices | 1 | 2016 | 26 | 0.130 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2016 | 26 | 0.120 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2015 | 8 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 85 | 0.120 |
Why?
| | Leukocidins | 1 | 2015 | 4 | 0.120 |
Why?
| | Trachea | 1 | 2017 | 235 | 0.120 |
Why?
| | Periplasmic Binding Proteins | 1 | 2015 | 13 | 0.120 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.120 |
Why?
| | Multigene Family | 2 | 2013 | 199 | 0.120 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 404 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 326 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 696 | 0.120 |
Why?
| | Enterotoxins | 2 | 2013 | 87 | 0.120 |
Why?
| | beta-Defensins | 1 | 2014 | 21 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 4 | 2021 | 115 | 0.120 |
Why?
| | Interleukin-8 | 3 | 2024 | 267 | 0.110 |
Why?
| | Carbon | 2 | 2013 | 223 | 0.110 |
Why?
| | Anthraquinones | 1 | 2014 | 11 | 0.110 |
Why?
| | Penicillium | 1 | 2014 | 7 | 0.110 |
Why?
| | Histocytochemistry | 1 | 2014 | 79 | 0.110 |
Why?
| | Kinetics | 4 | 2015 | 1668 | 0.110 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.110 |
Why?
| | Structural Homology, Protein | 1 | 2014 | 27 | 0.110 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 2014 | 5 | 0.110 |
Why?
| | Agglutination | 1 | 2013 | 5 | 0.110 |
Why?
| | Plant Leaves | 1 | 2015 | 145 | 0.110 |
Why?
| | Organisms, Genetically Modified | 1 | 2013 | 15 | 0.110 |
Why?
| | Virus Cultivation | 1 | 2014 | 29 | 0.110 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 180 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2010 | 376 | 0.110 |
Why?
| | DNA | 3 | 2022 | 1458 | 0.100 |
Why?
| | Nociceptors | 1 | 2013 | 38 | 0.100 |
Why?
| | Cysteine | 2 | 2018 | 205 | 0.100 |
Why?
| | Acyl-Butyrolactones | 1 | 2013 | 10 | 0.100 |
Why?
| | Heparitin Sulfate | 2 | 2023 | 50 | 0.100 |
Why?
| | Receptors, LDL | 1 | 2013 | 47 | 0.100 |
Why?
| | Apolipoproteins B | 1 | 2013 | 43 | 0.100 |
Why?
| | Triazoles | 1 | 2014 | 147 | 0.100 |
Why?
| | Blotting, Northern | 1 | 2013 | 199 | 0.100 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 43 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2018 | 914 | 0.100 |
Why?
| | Endopeptidase K | 2 | 2013 | 17 | 0.100 |
Why?
| | Surface Properties | 2 | 2014 | 414 | 0.100 |
Why?
| | Transcription Factors | 5 | 2022 | 1714 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2020 | 2473 | 0.100 |
Why?
| | Receptors, Interleukin-8B | 1 | 2012 | 26 | 0.100 |
Why?
| | Plants, Medicinal | 1 | 2012 | 22 | 0.100 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 77 | 0.100 |
Why?
| | Erythrocytes | 2 | 2015 | 692 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 442 | 0.100 |
Why?
| | Culture Media, Conditioned | 3 | 2020 | 110 | 0.100 |
Why?
| | Mycoplasma fermentans | 1 | 2012 | 1 | 0.100 |
Why?
| | Mutagenesis, Insertional | 3 | 2009 | 65 | 0.100 |
Why?
| | Phenol | 1 | 2012 | 19 | 0.090 |
Why?
| | Enzyme Therapy | 1 | 2011 | 4 | 0.090 |
Why?
| | Alleles | 3 | 2020 | 888 | 0.090 |
Why?
| | Vancomycin | 1 | 2013 | 84 | 0.090 |
Why?
| | Tetracyclines | 1 | 2011 | 11 | 0.090 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2011 | 16 | 0.090 |
Why?
| | Binding Sites | 3 | 2011 | 1308 | 0.090 |
Why?
| | Microarray Analysis | 3 | 2019 | 116 | 0.090 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2011 | 47 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 400 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 185 | 0.090 |
Why?
| | Incidence | 1 | 2018 | 2788 | 0.090 |
Why?
| | Cystic Fibrosis | 2 | 2012 | 1104 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 345 | 0.090 |
Why?
| | RNA Polymerase III | 1 | 2010 | 28 | 0.090 |
Why?
| | Protease Inhibitors | 2 | 2010 | 106 | 0.080 |
Why?
| | Autolysis | 1 | 2010 | 3 | 0.080 |
Why?
| | Citrate (si)-Synthase | 2 | 2001 | 60 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 500 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 608 | 0.080 |
Why?
| | Pheromones | 1 | 2010 | 25 | 0.080 |
Why?
| | Complement C3 | 1 | 2011 | 209 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 71 | 0.080 |
Why?
| | Chronic Disease | 1 | 2016 | 1784 | 0.080 |
Why?
| | Adenosine Triphosphate | 2 | 2002 | 486 | 0.080 |
Why?
| | Arthroplasty, Replacement | 1 | 2010 | 40 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 752 | 0.080 |
Why?
| | Biological Products | 1 | 2013 | 215 | 0.080 |
Why?
| | Cytokines | 4 | 2023 | 2088 | 0.080 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 5 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 556 | 0.080 |
Why?
| | Titanium | 1 | 2010 | 82 | 0.080 |
Why?
| | Shock, Septic | 1 | 2011 | 221 | 0.080 |
Why?
| | Ligands | 1 | 2011 | 664 | 0.080 |
Why?
| | Phenylmethylsulfonyl Fluoride | 1 | 2008 | 3 | 0.070 |
Why?
| | Time Factors | 5 | 2020 | 6792 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2014 | 343 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 804 | 0.070 |
Why?
| | Pain | 1 | 2013 | 755 | 0.070 |
Why?
| | Polymers | 2 | 2022 | 491 | 0.070 |
Why?
| | Gene Knockout Techniques | 3 | 2013 | 115 | 0.070 |
Why?
| | Prosthesis Design | 1 | 2010 | 324 | 0.070 |
Why?
| | Endopeptidase Clp | 1 | 2007 | 4 | 0.070 |
Why?
| | Lipopolysaccharides | 1 | 2011 | 885 | 0.070 |
Why?
| | Genetic Complementation Test | 3 | 2014 | 66 | 0.070 |
Why?
| | Mice, Knockout | 4 | 2018 | 2999 | 0.070 |
Why?
| | beta-Lactamases | 1 | 2007 | 47 | 0.070 |
Why?
| | Drug Synergism | 2 | 2020 | 378 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 451 | 0.070 |
Why?
| | Stimulation, Chemical | 1 | 2006 | 59 | 0.070 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 21 | 0.070 |
Why?
| | Burns | 1 | 2010 | 323 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7569 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2006 | 61 | 0.060 |
Why?
| | Respiratory Tract Infections | 1 | 2010 | 396 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 513 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2010 | 423 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 811 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 90 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 321 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2005 | 17 | 0.060 |
Why?
| | Interleukin-1beta | 2 | 2019 | 372 | 0.060 |
Why?
| | HIV Protease | 1 | 2004 | 4 | 0.060 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 811 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1181 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2005 | 64 | 0.060 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2004 | 10 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 59 | 0.060 |
Why?
| | Ribonucleotide Reductases | 1 | 2004 | 31 | 0.060 |
Why?
| | Tricarboxylic Acids | 1 | 2004 | 10 | 0.060 |
Why?
| | Bacillus subtilis | 2 | 2020 | 67 | 0.050 |
Why?
| | DNA Restriction Enzymes | 1 | 2004 | 52 | 0.050 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2004 | 23 | 0.050 |
Why?
| | Phenotype | 3 | 2021 | 3199 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2004 | 106 | 0.050 |
Why?
| | Databases, Genetic | 1 | 2005 | 236 | 0.050 |
Why?
| | Catalysis | 2 | 2002 | 316 | 0.050 |
Why?
| | Oligosaccharides | 1 | 2023 | 61 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 107 | 0.050 |
Why?
| | Coenzyme A | 1 | 2003 | 7 | 0.050 |
Why?
| | Acetate-CoA Ligase | 1 | 2003 | 2 | 0.050 |
Why?
| | Computational Biology | 2 | 2005 | 645 | 0.050 |
Why?
| | Cell Wall | 2 | 2013 | 58 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2548 | 0.050 |
Why?
| | Recombinases | 1 | 2022 | 6 | 0.050 |
Why?
| | Middle Aged | 3 | 2020 | 33200 | 0.050 |
Why?
| | Aged | 2 | 2023 | 23729 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 275 | 0.050 |
Why?
| | Oxidative Stress | 3 | 2014 | 1309 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 6 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 6 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Protein Stability | 2 | 2013 | 177 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 10 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 23 | 0.050 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 389 | 0.050 |
Why?
| | Leukocytes | 2 | 2015 | 312 | 0.050 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Cryoprotective Agents | 1 | 2002 | 10 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 849 | 0.050 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2002 | 53 | 0.050 |
Why?
| | U937 Cells | 2 | 2012 | 24 | 0.050 |
Why?
| | Hydrodynamics | 1 | 2022 | 42 | 0.050 |
Why?
| | Viscosity | 1 | 2022 | 92 | 0.050 |
Why?
| | Tyrosine | 1 | 2022 | 222 | 0.050 |
Why?
| | Brain | 1 | 2013 | 2669 | 0.050 |
Why?
| | Models, Chemical | 2 | 2002 | 268 | 0.050 |
Why?
| | Propylene Glycol | 2 | 1998 | 10 | 0.050 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 12 | 0.050 |
Why?
| | Adult | 3 | 2020 | 37616 | 0.050 |
Why?
| | Lipoylation | 1 | 2021 | 17 | 0.050 |
Why?
| | Photorhabdus | 1 | 2001 | 1 | 0.050 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2001 | 3 | 0.050 |
Why?
| | Proteolysis | 2 | 2012 | 178 | 0.050 |
Why?
| | Aconitic Acid | 1 | 2001 | 1 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 58 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2002 | 225 | 0.050 |
Why?
| | Nematoda | 1 | 2001 | 7 | 0.050 |
Why?
| | Oxaloacetic Acid | 1 | 2001 | 4 | 0.050 |
Why?
| | Glutamate Synthase | 1 | 2001 | 2 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 412 | 0.050 |
Why?
| | Codon, Initiator | 1 | 2001 | 10 | 0.040 |
Why?
| | Cell-Free System | 1 | 2001 | 53 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2001 | 59 | 0.040 |
Why?
| | Ecosystem | 1 | 2006 | 590 | 0.040 |
Why?
| | Protein Conformation | 3 | 2016 | 940 | 0.040 |
Why?
| | Pentanoic Acids | 1 | 2020 | 1 | 0.040 |
Why?
| | Isobutyrates | 1 | 2020 | 2 | 0.040 |
Why?
| | Hemiterpenes | 1 | 2020 | 11 | 0.040 |
Why?
| | Hemolysis | 2 | 2013 | 205 | 0.040 |
Why?
| | Sequence Deletion | 2 | 2012 | 183 | 0.040 |
Why?
| | Desmoglein 1 | 1 | 2020 | 2 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 345 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2002 | 616 | 0.040 |
Why?
| | Crystallography, X-Ray | 3 | 2011 | 485 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2020 | 120 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2023 | 310 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1756 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 57 | 0.040 |
Why?
| | Monocytes | 2 | 2013 | 561 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 523 | 0.040 |
Why?
| | Solubility | 1 | 2020 | 247 | 0.040 |
Why?
| | Luminescent Measurements | 1 | 2019 | 75 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2045 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1058 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 796 | 0.040 |
Why?
| | Phenols | 1 | 2020 | 100 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 636 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 1999 | 145 | 0.040 |
Why?
| | Interferon Type I | 1 | 2019 | 141 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2012 | 843 | 0.040 |
Why?
| | Nucleotidyltransferases | 1 | 1998 | 28 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 1998 | 68 | 0.040 |
Why?
| | Triglycerides | 1 | 2021 | 524 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2020 | 480 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2019 | 467 | 0.040 |
Why?
| | Survival Analysis | 2 | 2012 | 1319 | 0.040 |
Why?
| | Th17 Cells | 1 | 2019 | 109 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2018 | 173 | 0.040 |
Why?
| | Iron | 1 | 2019 | 311 | 0.030 |
Why?
| | Toxins, Biological | 1 | 2017 | 12 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 532 | 0.030 |
Why?
| | Nose | 1 | 2017 | 67 | 0.030 |
Why?
| | Genes, Regulator | 1 | 1997 | 37 | 0.030 |
Why?
| | Blood Coagulation | 1 | 2018 | 253 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 331 | 0.030 |
Why?
| | Immunoglobulin G | 2 | 2011 | 886 | 0.030 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 36 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 790 | 0.030 |
Why?
| | Ethanolamines | 1 | 1995 | 17 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 244 | 0.030 |
Why?
| | Propylene Glycols | 1 | 1995 | 28 | 0.030 |
Why?
| | DNA Polymerase I | 1 | 1995 | 29 | 0.030 |
Why?
| | Bronchi | 1 | 2017 | 260 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 618 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 969 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 28 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 60 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 19 | 0.030 |
Why?
| | Child | 3 | 2022 | 21968 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 101 | 0.030 |
Why?
| | Mice, Hairless | 1 | 2014 | 60 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 2014 | 51 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 145 | 0.030 |
Why?
| | Pyomyositis | 1 | 2014 | 15 | 0.030 |
Why?
| | Neisseria gonorrhoeae | 1 | 2014 | 25 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 112 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2014 | 150 | 0.030 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2013 | 3 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 52 | 0.030 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 54 | 0.030 |
Why?
| | Lymphatic Diseases | 1 | 2013 | 22 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 147 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2190 | 0.030 |
Why?
| | Fluorescence | 1 | 2014 | 159 | 0.030 |
Why?
| | Glyoxylates | 1 | 2013 | 10 | 0.030 |
Why?
| | Host Specificity | 1 | 2013 | 26 | 0.030 |
Why?
| | Fermentation | 1 | 2013 | 29 | 0.030 |
Why?
| | Oxidants | 1 | 2013 | 110 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 203 | 0.030 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 16 | 0.030 |
Why?
| | NADPH Oxidase 2 | 1 | 2013 | 39 | 0.030 |
Why?
| | Animals, Outbred Strains | 1 | 2012 | 5 | 0.030 |
Why?
| | Carbohydrates | 1 | 2013 | 66 | 0.030 |
Why?
| | Regulon | 1 | 2013 | 36 | 0.030 |
Why?
| | Oligonucleotides | 1 | 2014 | 148 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2015 | 344 | 0.020 |
Why?
| | Daptomycin | 1 | 2012 | 19 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 99 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 88 | 0.020 |
Why?
| | Acetates | 1 | 2013 | 99 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2014 | 160 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1861 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2013 | 123 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 52 | 0.020 |
Why?
| | Ion Transport | 1 | 2012 | 60 | 0.020 |
Why?
| | Immunoassay | 1 | 2013 | 113 | 0.020 |
Why?
| | Bicarbonates | 1 | 2012 | 44 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 425 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 813 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2012 | 80 | 0.020 |
Why?
| | Crystallization | 2 | 2003 | 145 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 138 | 0.020 |
Why?
| | Body Fluids | 1 | 2012 | 66 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2831 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 80 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 492 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 318 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 320 | 0.020 |
Why?
| | Glycerophosphates | 1 | 2011 | 3 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2011 | 23 | 0.020 |
Why?
| | Complement C3-C5 Convertases | 1 | 2011 | 24 | 0.020 |
Why?
| | Immunoglobulin Fragments | 1 | 2011 | 12 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2013 | 249 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2011 | 32 | 0.020 |
Why?
| | Complement C3b | 1 | 2011 | 34 | 0.020 |
Why?
| | Rodent Diseases | 1 | 2011 | 28 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 413 | 0.020 |
Why?
| | Mupirocin | 1 | 2010 | 7 | 0.020 |
Why?
| | Bacitracin | 1 | 2010 | 6 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 144 | 0.020 |
Why?
| | Polymyxin B | 1 | 2010 | 20 | 0.020 |
Why?
| | Neomycin | 1 | 2010 | 7 | 0.020 |
Why?
| | Complement C3a | 1 | 2011 | 42 | 0.020 |
Why?
| | Ointments | 1 | 2010 | 24 | 0.020 |
Why?
| | Bacteriolysis | 1 | 2010 | 9 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 307 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 100 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 973 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2011 | 225 | 0.020 |
Why?
| | Gentamicins | 1 | 2010 | 54 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 109 | 0.020 |
Why?
| | Meconium | 1 | 2010 | 7 | 0.020 |
Why?
| | Hot Temperature | 1 | 2013 | 392 | 0.020 |
Why?
| | Ileus | 1 | 2010 | 12 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2010 | 24 | 0.020 |
Why?
| | Action Potentials | 1 | 2013 | 495 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 843 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 442 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 409 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 728 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2012 | 251 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 72 | 0.020 |
Why?
| | Mucus | 1 | 2010 | 79 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2010 | 71 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 39 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 344 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 775 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 855 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2010 | 168 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2481 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 326 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 933 | 0.020 |
Why?
| | Complement Activation | 1 | 2011 | 411 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2010 | 1318 | 0.020 |
Why?
| | Caulobacter crescentus | 1 | 2007 | 2 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 1059 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 971 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 6731 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 890 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2012 | 846 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2162 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3272 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2831 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2603 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1998 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2003 | 202 | 0.010 |
Why?
| | Acetylation | 1 | 2003 | 248 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2624 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3566 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 663 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 21463 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 534 | 0.010 |
Why?
| | Reproduction | 1 | 2001 | 203 | 0.010 |
Why?
| | Pentosyltransferases | 1 | 1998 | 5 | 0.010 |
Why?
| | Ethanolamine | 1 | 1995 | 6 | 0.010 |
Why?
| | Sequence Analysis | 1 | 1995 | 36 | 0.010 |
Why?
| | Rats | 1 | 1995 | 5628 | 0.000 |
Why?
|
|
Horswill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|